Phase I study of domatinostat (4SC‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies |
| |
| Authors: | Bastian von Tresckow,Cyrus Sayehli,Walter E. Aulitzky,Maria‐Elisabeth Goebeler,Matthias Schwab,Eunice Braz,Babett Krauss,Rolf Krauss,Frank Hermann,Ren Bartz,Andreas Engert |
| |
| Affiliation: | Bastian von Tresckow,Cyrus Sayehli,Walter E. Aulitzky,Maria‐Elisabeth Goebeler,Matthias Schwab,Eunice Braz,Babett Krauss,Rolf Krauss,Frank Hermann,René Bartz,Andreas Engert |
| |
| Abstract: | |
| |
| Keywords: | 4SC‐202 domatinostat epigenetics HDAC inhibition hematological malignancies phase I study |
|
|
